Cosmetics & Toiletries has framed its 2026 Allēs program around base cosmetic ingredients — the emollients, emulsifiers, surfactants, humectants, structuring agents and preservatives that quietly carry nearly every formula on a formulator's bench. By placing foundational raw materials at the center of its editorial slate, the trade publication is signaling that 2026 will reward suppliers who can move the needle on texture, stability and skin feel, not just on flashy actives.

What does C&T mean by a "base" ingredient?

The Allēs category covers the structural workhorses of cosmetic chemistry rather than the headline-grabbing actives that typically dominate trade press. Formulators reach for these materials to build a chassis: an emulsifier such as a fatty acid ester or a polysorbate holds oil and water together; an emollient like isoamyl cocoate or squalane controls slip and cushion; a surfactant such as sodium cocoyl isethionate drives foam; a humectant like glycerin pulls water into the stratum corneum; a polymer or wax structures the formula; and a preservative system — phenoxyethanol blends, organic acids or modern alternatives — keeps the microbiological profile in check. When C&T uses "base," it speaks to ingredients consumed at percentages measured in single digits to tens of percent per formula, not the trace-level peptides and botanical extracts that earn much of the marketing oxygen.

Why is the 2026 timing notable?

Base ingredients rarely generate press releases on their own, so a dedicated editorial frame is a useful cue for R&D directors and procurement teams. Three macro pressures make the timing consequential. First, the EU microplastics restriction has reshaped the polymer and film-former landscape, pushing suppliers to replace polyethylene-derived scrub beads and acrylate copolymers with biodegradable alternatives; formulators sourcing exfoliants and styling resins should expect new INCI entries and revised specification sheets through 2025 and 2026. Second, the surfactant category continues its pivot toward mild, sulfate-free systems — sodium cocoyl isethionate, disodium laureth sulfosuccinate, alkyl polyglucosides — driven by both consumer demand and tightening rinse-off classification under EU Regulation 1223/2009. Third, preservation remains a moving target after the 2019 and subsequent SCCS opinions on phenoxyethanol and isothiazolinones, with brands trialing multifunctional blends that combine chelators, organic acids and traditional preservatives at lower use levels.

What should formulators watch in the run-up?

Three data points deserve attention between now and the Allēs reveal:

• New INCI entries on CosIng and the USPCID. Suppliers positioning base ingredients for 2026 recognition typically file new INCI names months ahead, so scanning the EU CosIng database and the US Personal Care Product Council's International Cosmetic Ingredient Dictionary for fresh nomenclature is a leading indicator.
• Supplier technical dossiers with use-level data. Base ingredients earn Allēs recognition on performance, not marketing, so watch for datasheets specifying percentage ranges, pH tolerance, electrolyte compatibility and challenge test outcomes.
• Regulatory milestones through 2025. EU SCCS mandates on individual preservatives, the next iteration of the EU Green Deal's chemical strategy, and any FDA over-the-counter monograph updates will all reshape which base ingredients formulators can legally deploy at the levels their formulas require.

For procurement, the editorial focus on bases is a prompt to revisit long-term supply contracts on emulsifiers and surfactants in particular — these categories saw the most volatility during the 2021-2023 oleochemical crunch and remain sensitive to palm, coconut and rapeseed feedstock pricing.

What changes for product development?

Treat the Allēs coverage as a barometer, not a buyer's guide. Winners in the base category tend to be materials already in use at major contract manufacturers rather than laboratory curiosities, which means the recognition rewards scalability, regulatory clearance across major markets and reproducible sensory performance. Formulators evaluating nominees should compare each entry against three filters: documented multifunctionality (does it replace two existing ingredients?), regulatory status across the EU, US, ASEAN and China NMPA, and supplier capacity to deliver at multi-ton scale.

The next concrete data point to watch is C&T's annual Allēs shortlist, typically released in the fourth quarter. Until then, the smartest move for R&D and procurement teams is to map current base-ingredient portfolios against the regulatory and feedstock pressures reshaping those chemistries, so the Allēs announcement lands as confirmation rather than surprise.